UK Markets open in 3 hrs 29 mins

Global Preimplantation Genetic Testing Market to Reach $937.8 Million by 2027

ReportLinker
ReportLinker

In the changed post COVID-19 business landscape, the global market for Preimplantation Genetic Testing estimated at US$435. 2 Million in the year 2020, is projected to reach a revised size of US$937.

New York, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Preimplantation Genetic Testing Industry" - https://www.reportlinker.com/p06032644/?utm_source=GNW
8 Million by 2027, growing at a CAGR of 11.6% over the analysis period 2020-2027. Reagents & Consumables, one of the segments analyzed in the report, is projected to record a 12.3% CAGR and reach US$494.3 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised 10.6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $127.3 Million, While China is Forecast to Grow at 11% CAGR

The Preimplantation Genetic Testing market in the U.S. is estimated at US$127.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$162.6 Million by the year 2027 trailing a CAGR of 11% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.9% and 9.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.6% CAGR.

Software & Services Segment to Record 11.2% CAGR

In the global Software & Services segment, USA, Canada, Japan, China and Europe will drive the 11.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$73.2 Million in the year 2020 will reach a projected size of US$154.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

Select Competitors (Total 34 Featured) -
Ariosa Diagnostics
Bioarray S.L.
California Pacific Medical Center (CPMC)
CombiMatrix
CooperSurgical, Inc.
F. Hoffmann-La Roche Ltd.
Genea Limited
Genesis Genetics
Good Start Genetics, Inc.
IGENOMIX
Illumina, Inc.
Invitae Corporation
Laboratory Corporation of America Holdings
Natera, Inc.
Oxford Gene Technology
PerkinElmer Inc.
Quest Diagnostics Incorporated
Reproductive Genetic Innovations, LLC
Reprogenetics
RHS Ltd.
Sequenom
Thermo Fisher Scientific, Inc.


Read the full report: https://www.reportlinker.com/p06032644/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Preimplantation Genetic Testing - Global Key Competitors
Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Preimplantation Genetic Testing by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Preimplantation Genetic
Testing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 3: World 15-Year Perspective for Preimplantation Genetic
Testing by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets for Years 2012, 2021 & 2027

Table 4: World Recent Past, Current & Future Analysis for
Reagents & Consumables by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 5: World Historic Review for Reagents & Consumables by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Reagents & Consumables
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 7: World Recent Past, Current & Future Analysis for
Instruments by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 8: World Historic Review for Instruments by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Instruments by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 10: World Recent Past, Current & Future Analysis for
Software & Services by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Software & Services by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Software & Services by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 13: World Recent Past, Current & Future Analysis for
Research Laboratories & Academic Institutes by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Research Laboratories &
Academic Institutes by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Research Laboratories &
Academic Institutes by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2012, 2021 & 2027

Table 16: World Recent Past, Current & Future Analysis for
Maternity Centers & Fertility Clinics by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Maternity Centers &
Fertility Clinics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Maternity Centers &
Fertility Clinics by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2012, 2021 & 2027

Table 19: World Recent Past, Current & Future Analysis for
Hospitals, Diagnostic Labs & Service Providers by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Hospitals, Diagnostic Labs &
Service Providers by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Hospitals, Diagnostic
Labs & Service Providers by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2012, 2021 & 2027

Table 22: World Recent Past, Current & Future Analysis for Next
Generation Sequencing (NGS) by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 23: World Historic Review for Next Generation Sequencing
(NGS) by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 24: World 15-Year Perspective for Next Generation
Sequencing (NGS) by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2012, 2021 & 2027

Table 25: World Recent Past, Current & Future Analysis for
Polymerase Chain Reaction (PCR) by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 26: World Historic Review for Polymerase Chain Reaction
(PCR) by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 27: World 15-Year Perspective for Polymerase Chain
Reaction (PCR) by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2012, 2021 & 2027

Table 28: World Recent Past, Current & Future Analysis for
Fluorescent In-Situ Hybridization (FISH) by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 29: World Historic Review for Fluorescent In-Situ
Hybridization (FISH) by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 30: World 15-Year Perspective for Fluorescent In-Situ
Hybridization (FISH) by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2012, 2021 & 2027

Table 31: World Recent Past, Current & Future Analysis for
Other Technologies by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 32: World Historic Review for Other Technologies by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 33: World 15-Year Perspective for Other Technologies by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 34: World Preimplantation Genetic Testing Market Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2027

III. MARKET ANALYSIS

UNITED STATES
Preimplantation Genetic Testing Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in the United States
for 2022 (E)
Table 35: USA Recent Past, Current & Future Analysis for
Preimplantation Genetic Testing by Component - Reagents &
Consumables, Instruments and Software & Services - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 36: USA Historic Review for Preimplantation Genetic
Testing by Component - Reagents & Consumables, Instruments and
Software & Services Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 37: USA 15-Year Perspective for Preimplantation Genetic
Testing by Component - Percentage Breakdown of Value Sales for
Reagents & Consumables, Instruments and Software & Services for
the Years 2012, 2021 & 2027

Table 38: USA Recent Past, Current & Future Analysis for
Preimplantation Genetic Testing by End-Use - Research
Laboratories & Academic Institutes, Maternity Centers &
Fertility Clinics and Hospitals, Diagnostic Labs & Service
Providers - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 39: USA Historic Review for Preimplantation Genetic
Testing by End-Use - Research Laboratories & Academic
Institutes, Maternity Centers & Fertility Clinics and
Hospitals, Diagnostic Labs & Service Providers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 40: USA 15-Year Perspective for Preimplantation Genetic
Testing by End-Use - Percentage Breakdown of Value Sales for
Research Laboratories & Academic Institutes, Maternity Centers &
Fertility Clinics and Hospitals, Diagnostic Labs & Service
Providers for the Years 2012, 2021 & 2027

Table 41: USA Recent Past, Current & Future Analysis for
Preimplantation Genetic Testing by Technology - Next Generation
Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent
In-Situ Hybridization (FISH) and Other Technologies -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 42: USA Historic Review for Preimplantation Genetic
Testing by Technology - Next Generation Sequencing (NGS),
Polymerase Chain Reaction (PCR), Fluorescent In-Situ
Hybridization (FISH) and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 43: USA 15-Year Perspective for Preimplantation Genetic
Testing by Technology - Percentage Breakdown of Value Sales for
Next Generation Sequencing (NGS), Polymerase Chain Reaction
(PCR), Fluorescent In-Situ Hybridization (FISH) and Other
Technologies for the Years 2012, 2021 & 2027

CANADA
Table 44: Canada Recent Past, Current & Future Analysis for
Preimplantation Genetic Testing by Component - Reagents &
Consumables, Instruments and Software & Services - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 45: Canada Historic Review for Preimplantation Genetic
Testing by Component - Reagents & Consumables, Instruments and
Software & Services Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 46: Canada 15-Year Perspective for Preimplantation
Genetic Testing by Component - Percentage Breakdown of Value
Sales for Reagents & Consumables, Instruments and Software &
Services for the Years 2012, 2021 & 2027

Table 47: Canada Recent Past, Current & Future Analysis for
Preimplantation Genetic Testing by End-Use - Research
Laboratories & Academic Institutes, Maternity Centers &
Fertility Clinics and Hospitals, Diagnostic Labs & Service
Providers - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 48: Canada Historic Review for Preimplantation Genetic
Testing by End-Use - Research Laboratories & Academic
Institutes, Maternity Centers & Fertility Clinics and
Hospitals, Diagnostic Labs & Service Providers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 49: Canada 15-Year Perspective for Preimplantation
Genetic Testing by End-Use - Percentage Breakdown of Value
Sales for Research Laboratories & Academic Institutes,
Maternity Centers & Fertility Clinics and Hospitals, Diagnostic
Labs & Service Providers for the Years 2012, 2021 & 2027

Table 50: Canada Recent Past, Current & Future Analysis for
Preimplantation Genetic Testing by Technology - Next Generation
Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent
In-Situ Hybridization (FISH) and Other Technologies -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 51: Canada Historic Review for Preimplantation Genetic
Testing by Technology - Next Generation Sequencing (NGS),
Polymerase Chain Reaction (PCR), Fluorescent In-Situ
Hybridization (FISH) and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 52: Canada 15-Year Perspective for Preimplantation
Genetic Testing by Technology - Percentage Breakdown of Value
Sales for Next Generation Sequencing (NGS), Polymerase Chain
Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and
Other Technologies for the Years 2012, 2021 & 2027

JAPAN
Preimplantation Genetic Testing Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
Table 53: Japan Recent Past, Current & Future Analysis for
Preimplantation Genetic Testing by Component - Reagents &
Consumables, Instruments and Software & Services - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 54: Japan Historic Review for Preimplantation Genetic
Testing by Component - Reagents & Consumables, Instruments and
Software & Services Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 55: Japan 15-Year Perspective for Preimplantation Genetic
Testing by Component - Percentage Breakdown of Value Sales for
Reagents & Consumables, Instruments and Software & Services for
the Years 2012, 2021 & 2027

Table 56: Japan Recent Past, Current & Future Analysis for
Preimplantation Genetic Testing by End-Use - Research
Laboratories & Academic Institutes, Maternity Centers &
Fertility Clinics and Hospitals, Diagnostic Labs & Service
Providers - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 57: Japan Historic Review for Preimplantation Genetic
Testing by End-Use - Research Laboratories & Academic
Institutes, Maternity Centers & Fertility Clinics and
Hospitals, Diagnostic Labs & Service Providers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 58: Japan 15-Year Perspective for Preimplantation Genetic
Testing by End-Use - Percentage Breakdown of Value Sales for
Research Laboratories & Academic Institutes, Maternity Centers &
Fertility Clinics and Hospitals, Diagnostic Labs & Service
Providers for the Years 2012, 2021 & 2027

Table 59: Japan Recent Past, Current & Future Analysis for
Preimplantation Genetic Testing by Technology - Next Generation
Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent
In-Situ Hybridization (FISH) and Other Technologies -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 60: Japan Historic Review for Preimplantation Genetic
Testing by Technology - Next Generation Sequencing (NGS),
Polymerase Chain Reaction (PCR), Fluorescent In-Situ
Hybridization (FISH) and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 61: Japan 15-Year Perspective for Preimplantation Genetic
Testing by Technology - Percentage Breakdown of Value Sales for
Next Generation Sequencing (NGS), Polymerase Chain Reaction
(PCR), Fluorescent In-Situ Hybridization (FISH) and Other
Technologies for the Years 2012, 2021 & 2027

CHINA
Preimplantation Genetic Testing Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in China for 2022 (E)
Table 62: China Recent Past, Current & Future Analysis for
Preimplantation Genetic Testing by Component - Reagents &
Consumables, Instruments and Software & Services - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 63: China Historic Review for Preimplantation Genetic
Testing by Component - Reagents & Consumables, Instruments and
Software & Services Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 64: China 15-Year Perspective for Preimplantation Genetic
Testing by Component - Percentage Breakdown of Value Sales for
Reagents & Consumables, Instruments and Software & Services for
the Years 2012, 2021 & 2027

Table 65: China Recent Past, Current & Future Analysis for
Preimplantation Genetic Testing by End-Use - Research
Laboratories & Academic Institutes, Maternity Centers &
Fertility Clinics and Hospitals, Diagnostic Labs & Service
Providers - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 66: China Historic Review for Preimplantation Genetic
Testing by End-Use - Research Laboratories & Academic
Institutes, Maternity Centers & Fertility Clinics and
Hospitals, Diagnostic Labs & Service Providers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 67: China 15-Year Perspective for Preimplantation Genetic
Testing by End-Use - Percentage Breakdown of Value Sales for
Research Laboratories & Academic Institutes, Maternity Centers &
Fertility Clinics and Hospitals, Diagnostic Labs & Service
Providers for the Years 2012, 2021 & 2027

Table 68: China Recent Past, Current & Future Analysis for
Preimplantation Genetic Testing by Technology - Next Generation
Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent
In-Situ Hybridization (FISH) and Other Technologies -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 69: China Historic Review for Preimplantation Genetic
Testing by Technology - Next Generation Sequencing (NGS),
Polymerase Chain Reaction (PCR), Fluorescent In-Situ
Hybridization (FISH) and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 70: China 15-Year Perspective for Preimplantation Genetic
Testing by Technology - Percentage Breakdown of Value Sales for
Next Generation Sequencing (NGS), Polymerase Chain Reaction
(PCR), Fluorescent In-Situ Hybridization (FISH) and Other
Technologies for the Years 2012, 2021 & 2027

EUROPE
Preimplantation Genetic Testing Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Table 71: Europe Recent Past, Current & Future Analysis for
Preimplantation Genetic Testing by Geographic Region - France,
Germany, Italy, UK and Rest of Europe Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 72: Europe Historic Review for Preimplantation Genetic
Testing by Geographic Region - France, Germany, Italy, UK and
Rest of Europe Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 73: Europe 15-Year Perspective for Preimplantation
Genetic Testing by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK and Rest of Europe
Markets for Years 2012, 2021 & 2027

Table 74: Europe Recent Past, Current & Future Analysis for
Preimplantation Genetic Testing by Component - Reagents &
Consumables, Instruments and Software & Services - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 75: Europe Historic Review for Preimplantation Genetic
Testing by Component - Reagents & Consumables, Instruments and
Software & Services Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 76: Europe 15-Year Perspective for Preimplantation
Genetic Testing by Component - Percentage Breakdown of Value
Sales for Reagents & Consumables, Instruments and Software &
Services for the Years 2012, 2021 & 2027

Table 77: Europe Recent Past, Current & Future Analysis for
Preimplantation Genetic Testing by End-Use - Research
Laboratories & Academic Institutes, Maternity Centers &
Fertility Clinics and Hospitals, Diagnostic Labs & Service
Providers - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 78: Europe Historic Review for Preimplantation Genetic
Testing by End-Use - Research Laboratories & Academic
Institutes, Maternity Centers & Fertility Clinics and
Hospitals, Diagnostic Labs & Service Providers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 79: Europe 15-Year Perspective for Preimplantation
Genetic Testing by End-Use - Percentage Breakdown of Value
Sales for Research Laboratories & Academic Institutes,
Maternity Centers & Fertility Clinics and Hospitals, Diagnostic
Labs & Service Providers for the Years 2012, 2021 & 2027

Table 80: Europe Recent Past, Current & Future Analysis for
Preimplantation Genetic Testing by Technology - Next Generation
Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent
In-Situ Hybridization (FISH) and Other Technologies -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 81: Europe Historic Review for Preimplantation Genetic
Testing by Technology - Next Generation Sequencing (NGS),
Polymerase Chain Reaction (PCR), Fluorescent In-Situ
Hybridization (FISH) and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 82: Europe 15-Year Perspective for Preimplantation
Genetic Testing by Technology - Percentage Breakdown of Value
Sales for Next Generation Sequencing (NGS), Polymerase Chain
Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and
Other Technologies for the Years 2012, 2021 & 2027

FRANCE
Preimplantation Genetic Testing Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in France for 2022 (E)
Table 83: France Recent Past, Current & Future Analysis for
Preimplantation Genetic Testing by Component - Reagents &
Consumables, Instruments and Software & Services - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 84: France Historic Review for Preimplantation Genetic
Testing by Component - Reagents & Consumables, Instruments and
Software & Services Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 85: France 15-Year Perspective for Preimplantation
Genetic Testing by Component - Percentage Breakdown of Value
Sales for Reagents & Consumables, Instruments and Software &
Services for the Years 2012, 2021 & 2027

Table 86: France Recent Past, Current & Future Analysis for
Preimplantation Genetic Testing by End-Use - Research
Laboratories & Academic Institutes, Maternity Centers &
Fertility Clinics and Hospitals, Diagnostic Labs & Service
Providers - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 87: France Historic Review for Preimplantation Genetic
Testing by End-Use - Research Laboratories & Academic
Institutes, Maternity Centers & Fertility Clinics and
Hospitals, Diagnostic Labs & Service Providers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 88: France 15-Year Perspective for Preimplantation
Genetic Testing by End-Use - Percentage Breakdown of Value
Sales for Research Laboratories & Academic Institutes,
Maternity Centers & Fertility Clinics and Hospitals, Diagnostic
Labs & Service Providers for the Years 2012, 2021 & 2027

Table 89: France Recent Past, Current & Future Analysis for
Preimplantation Genetic Testing by Technology - Next Generation
Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent
In-Situ Hybridization (FISH) and Other Technologies -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 90: France Historic Review for Preimplantation Genetic
Testing by Technology - Next Generation Sequencing (NGS),
Polymerase Chain Reaction (PCR), Fluorescent In-Situ
Hybridization (FISH) and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 91: France 15-Year Perspective for Preimplantation
Genetic Testing by Technology - Percentage Breakdown of Value
Sales for Next Generation Sequencing (NGS), Polymerase Chain
Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and
Other Technologies for the Years 2012, 2021 & 2027

GERMANY
Preimplantation Genetic Testing Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
Table 92: Germany Recent Past, Current & Future Analysis for
Preimplantation Genetic Testing by Component - Reagents &
Consumables, Instruments and Software & Services - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 93: Germany Historic Review for Preimplantation Genetic
Testing by Component - Reagents & Consumables, Instruments and
Software & Services Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 94: Germany 15-Year Perspective for Preimplantation
Genetic Testing by Component - Percentage Breakdown of Value
Sales for Reagents & Consumables, Instruments and Software &
Services for the Years 2012, 2021 & 2027

Table 95: Germany Recent Past, Current & Future Analysis for
Preimplantation Genetic Testing by End-Use - Research
Laboratories & Academic Institutes, Maternity Centers &
Fertility Clinics and Hospitals, Diagnostic Labs & Service
Providers - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 96: Germany Historic Review for Preimplantation Genetic
Testing by End-Use - Research Laboratories & Academic
Institutes, Maternity Centers & Fertility Clinics and
Hospitals, Diagnostic Labs & Service Providers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 97: Germany 15-Year Perspective for Preimplantation
Genetic Testing by End-Use - Percentage Breakdown of Value
Sales for Research Laboratories & Academic Institutes,
Maternity Centers & Fertility Clinics and Hospitals, Diagnostic
Labs & Service Providers for the Years 2012, 2021 & 2027

Table 98: Germany Recent Past, Current & Future Analysis for
Preimplantation Genetic Testing by Technology - Next Generation
Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent
In-Situ Hybridization (FISH) and Other Technologies -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 99: Germany Historic Review for Preimplantation Genetic
Testing by Technology - Next Generation Sequencing (NGS),
Polymerase Chain Reaction (PCR), Fluorescent In-Situ
Hybridization (FISH) and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 100: Germany 15-Year Perspective for Preimplantation
Genetic Testing by Technology - Percentage Breakdown of Value
Sales for Next Generation Sequencing (NGS), Polymerase Chain
Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and
Other Technologies for the Years 2012, 2021 & 2027

ITALY
Table 101: Italy Recent Past, Current & Future Analysis for
Preimplantation Genetic Testing by Component - Reagents &
Consumables, Instruments and Software & Services - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 102: Italy Historic Review for Preimplantation Genetic
Testing by Component - Reagents & Consumables, Instruments and
Software & Services Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 103: Italy 15-Year Perspective for Preimplantation
Genetic Testing by Component - Percentage Breakdown of Value
Sales for Reagents & Consumables, Instruments and Software &
Services for the Years 2012, 2021 & 2027

Table 104: Italy Recent Past, Current & Future Analysis for
Preimplantation Genetic Testing by End-Use - Research
Laboratories & Academic Institutes, Maternity Centers &
Fertility Clinics and Hospitals, Diagnostic Labs & Service
Providers - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 105: Italy Historic Review for Preimplantation Genetic
Testing by End-Use - Research Laboratories & Academic
Institutes, Maternity Centers & Fertility Clinics and
Hospitals, Diagnostic Labs & Service Providers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 106: Italy 15-Year Perspective for Preimplantation
Genetic Testing by End-Use - Percentage Breakdown of Value
Sales for Research Laboratories & Academic Institutes,
Maternity Centers & Fertility Clinics and Hospitals, Diagnostic
Labs & Service Providers for the Years 2012, 2021 & 2027

Table 107: Italy Recent Past, Current & Future Analysis for
Preimplantation Genetic Testing by Technology - Next Generation
Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent
In-Situ Hybridization (FISH) and Other Technologies -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 108: Italy Historic Review for Preimplantation Genetic
Testing by Technology - Next Generation Sequencing (NGS),
Polymerase Chain Reaction (PCR), Fluorescent In-Situ
Hybridization (FISH) and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 109: Italy 15-Year Perspective for Preimplantation
Genetic Testing by Technology - Percentage Breakdown of Value
Sales for Next Generation Sequencing (NGS), Polymerase Chain
Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and
Other Technologies for the Years 2012, 2021 & 2027

UNITED KINGDOM

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032644/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001